Clínica de Marly S.A. (BVC:MARLY)

Clínica de Marly Income Statement

Financials in millions COP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	434,511	413,169	362,905	321,343	278,599	209,776
Revenue Growth (YoY)	8.74%	13.85%	12.93%	15.34%	32.81%	-15.90%
Cost of Revenue	269,151	256,982	231,992	208,407	178,364	144,716
Gross Profit	165,360	156,187	130,913	112,935	100,234	65,060
Selling, General & Admin	62,947	40,774	36,964	33,870	28,018	26,881
Amortization of Goodwill & Intangibles	240.5	904.1	849.82	492.11	401.94	293.1
Other Operating Expenses	1,236	5,608	5,453	3,985	3,091	2,401
Operating Expenses	65,653	52,087	47,948	43,641	36,557	35,008
Operating Income	99,707	104,100	82,965	69,294	63,678	30,052
Interest Expense	-5,598	-1,364	-2,324	-2,206	-1,608	-2,605
Interest & Investment Income	4,437	16,025	12,491	5,805	1,749	3,697
Earnings From Equity Investments	10,440	36,628	21,135	19,381	18,419	4,091
Currency Exchange Gain (Loss)	988.36	2,345	-3,530	2,616	2,421	133.45
Other Non Operating Income (Expenses)	21,976	-21,831	-8,019	-12,403	-12,456	5,858
EBT Excluding Unusual Items	131,951	135,903	102,718	82,487	72,203	41,227
Gain (Loss) on Sale of Investments	131.19	233.45	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	26.91	23.36
Asset Writedown	-884.01	-8,460	-7,413	-550.3	-1,958	-1,134
Pretax Income	131,198	127,676	95,306	81,936	70,271	40,117
Income Tax Expense	41,049	38,820	30,536	26,642	20,467	12,280
Earnings From Continuing Operations	90,148	88,856	64,770	55,295	49,804	27,836
Minority Interest in Earnings	-891.53	-1,121	-89.46	-713.74	-830.06	-385.4
Net Income	89,257	87,735	64,681	54,581	48,974	27,451
Net Income to Common	89,257	87,735	64,681	54,581	48,974	27,451
Net Income Growth	10.45%	35.64%	18.50%	11.45%	78.41%	-26.87%
Shares Outstanding (Basic)	-	-	11	11	11	11
Shares Outstanding (Diluted)	-	-	11	11	11	11
EPS (Basic)	-	-	6057.41	5111.57	4586.50	2570.82
EPS (Diluted)	-	-	6057.41	5111.57	4586.50	2570.82
EPS Growth	-	-	18.50%	11.45%	78.41%	-26.87%
Free Cash Flow	19,785	-422.9	23,300	27,495	16,504	22,531
Free Cash Flow Per Share	-	-	2182.04	2574.90	1545.65	2110.04
Dividend Per Share	1596.000	1596.000	1200.000	696.000	564.000	-
Dividend Growth	33.00%	33.00%	72.41%	23.40%	-	-
Gross Margin	38.06%	37.80%	36.07%	35.14%	35.98%	31.01%
Operating Margin	22.95%	25.20%	22.86%	21.56%	22.86%	14.33%
Profit Margin	20.54%	21.23%	17.82%	16.98%	17.58%	13.09%
Free Cash Flow Margin	4.55%	-0.10%	6.42%	8.56%	5.92%	10.74%
EBITDA	107,152	109,736	88,446	75,033	69,075	35,727
EBITDA Margin	24.66%	26.56%	24.37%	23.35%	24.79%	17.03%
D&A For EBITDA	7,444	5,635	5,480	5,739	5,397	5,674
EBIT	99,707	104,100	82,965	69,294	63,678	30,052
EBIT Margin	22.95%	25.20%	22.86%	21.56%	22.86%	14.33%
Effective Tax Rate	31.29%	30.40%	32.04%	32.52%	29.13%	30.61%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.